Oral submucous fibrosis: etiological mechanism, malignant transformation, therapeutic approaches and targets
X Qin, Y Ning, L Zhou, Y Zhu - International journal of molecular sciences, 2023 - mdpi.com
Oral submucosal fibrosis (OSF) is a chronic, progressive and potentially malignant oral
disorder with a high regional incidence and malignant rate. With the development of the …
disorder with a high regional incidence and malignant rate. With the development of the …
Are there betel quid mixtures less harmful than others? A scoping review of the association between different betel quid ingredients and the risk of oral submucous …
N Cirillo, PH Duong, WT Er, CTN Do, MEH De Silva… - Biomolecules, 2022 - mdpi.com
Oral submucous fibrosis (OSF) is a potentially malignant condition of the oral cavity
characterized by progressive fibrosis of the submucosal tissues. OSF is typically associated …
characterized by progressive fibrosis of the submucosal tissues. OSF is typically associated …
Metabolomic profile of Indonesian betel quids
Consumption of areca nut alone, or in the form of betel quid (BQ), has negative health effects
and is carcinogenic to humans. Indonesia is one of the largest producers of areca nuts …
and is carcinogenic to humans. Indonesia is one of the largest producers of areca nuts …
Mechanisms and markers of malignant transformation of oral submucous fibrosis
F Lin, T Xiao, B Wang, L Wang, G Liu, R Wang, C Xie… - Heliyon, 2024 - cell.com
Oral submucous fibrosis (OSF) is a chronic premalignant disease associated with betel quid
chewing. Epidemiological studies indicate that there are approximately 5 million individuals …
chewing. Epidemiological studies indicate that there are approximately 5 million individuals …
Therapeutic Potential and Mechanisms of Rosmarinic Acid and the Extracts of Lamiaceae Plants for the Treatment of Fibrosis of Various Organs
YC Boo - Antioxidants, 2024 - mdpi.com
Fibrosis, which causes structural hardening and functional degeneration in various organs,
is characterized by the excessive production and accumulation of connective tissue …
is characterized by the excessive production and accumulation of connective tissue …
MiR-424/TGIF2-mediated pro-fibrogenic responses in oral submucous fibrosis
MY Chou, PL Hsieh, SC Chao, YW Liao, CC Yu… - International Journal of …, 2023 - mdpi.com
Oral submucous fibrosis (OSF) has been recognized as a potentially malignant disorder and
is characterized by inflammation and the deposition of collagen. Among various regulators …
is characterized by inflammation and the deposition of collagen. Among various regulators …
New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma
I Dewenter, J Kumbrink, P Poxleitner, W Smolka… - Oral Oncology, 2023 - Elsevier
Oral squamous cell carcinoma (OSCC) is the most common cancer in the oral cavity
accounting for 90% of oral cancer with a global incidence of 350.000 new cases per year …
accounting for 90% of oral cancer with a global incidence of 350.000 new cases per year …
Antioxidant treatments in patients with oral submucous fibrosis: A systematic review
M Pérez‐Leal, F Lanciano, N Flacco… - Journal of Oral …, 2024 - Wiley Online Library
Introduction Oral submucous fibrosis (OSMF) is a well‐known precancerous oral lesion,
characterized by scarring, tissue fibrosis, and premalignant lesions. The goal of clinical …
characterized by scarring, tissue fibrosis, and premalignant lesions. The goal of clinical …
Antifibrotic effect of silymarin on arecoline-induced fibrosis in primary human buccal fibroblasts: an in silico and in vitro analysis
DC Venugopal, P Viswanathan, S Ravindran… - Molecular Biology …, 2024 - Springer
Background This study aimed to assess silymarin's anticancer and antifibrotic potential
through in silico analysis and investigate its impact on in vitro arecoline-induced fibrosis in …
through in silico analysis and investigate its impact on in vitro arecoline-induced fibrosis in …
Comparison of triamcinolone with pentoxifylline and vitamin E efficacy in the treatment of stage 2 and 3 oral submucous fibrosis: A randomized clinical trial
Objective: The objective of this study was to assess the effectiveness of triamcinolone in
combination with pentoxifylline and vitamin E in the treatment of patients with level two and …
combination with pentoxifylline and vitamin E in the treatment of patients with level two and …